Saguaro

News

Saguaro and Funakoshi Enter Distribution Agreement to make New Non-Toxic Dye Technology Available to Japan

Nov 17, 2022. QUEBEC CITY & TOKYO — Saguaro Technologies inc., a cell culture product company that offers a first-of-a-kind dye technology, and Funakoshi Co., Ltd., a top Japanese distributor of life science reagents and products, announces the establishment of a new distribution agreement where Funakoshi will help Saguaro accelerate sales of its products to …

Saguaro and Funakoshi Enter Distribution Agreement to make New Non-Toxic Dye Technology Available to Japan Read More »

Saguaro Closes $1.1M Start-Up Funding to Offer New Drug Discovery Technologies That Help Fight Human Disease

February 16, 2022. Saguaro Technologies Inc. announces the closing of a $1.1M start-up financing led by a seasoned biotech investor and including non-dilutive grant funding. “We are pleased to close our first financing and to welcome Frederic Ors as lead investor and strategic advisor to Saguaro. Frederic is a well-recognized executive with a track-record of …

Saguaro Closes $1.1M Start-Up Funding to Offer New Drug Discovery Technologies That Help Fight Human Disease Read More »

New drugs: Saguaro closes $1.1M financing

February 16, 2022. The young biotech company Saguaro Technologies inc. closes its $1.1M seed funding and welcomes Frédéric Ors, seasoned biotech investor and strategic advisor. Mr Ors joins the two co-founders of Saguaro, Louis Turcotte and Félix Lavoie-Pérusse

Saguaro Announces Exclusive Worldwide License Agreement with Sunnybrook Research Institute for ChromaLive™ dyes

March 23, 2022. Saguaro Technologies inc. announces an exclusive worldwide license agreement with Sunnybrook Research Institute (SRI) on non-toxic small molecules for live-cell imaging. These new molecules, which are now part of Saguaro’s proprietary series of high-performance dyes (ChromaLive TM), were developed by David Andrews, PhD, Director of Biological Sciences at Sunnybrook Research Institute.

Fill the form



Fill the form



Fill the form



Fill the form